| Last Action | 01/13/21: to Committee on Committees (S) |
|---|---|
| Title | AN ACT relating to prescription insulin and declaring an emergency. |
| Bill Documents | Introduced |
| Fiscal Impact Statement | Health Mandate |
| Bill Request Number | 1177 |
| Sponsors | P. Wheeler, J. Turner, R. Girdler, A. Kerr, M. Nemes, D. Yates |
| Summary of Original Version | Create various new sections of KRS Chapter 211 to define terms; establish the urgent-need insulin program and the continuing access to insulin program; establish eligibility guidelines for both programs; establish the application process; establish the process by which insulin is dispensed to eligible individuals; establish the responsibilities of insulin manufacturers for facilitating the dispensing of insulin to eligible individuals; establish the responsibilities of the Cabinet for Health and Family Services for administering the program; require manufacturers to maintain privacy of all data obtained; require manufacturers to annually report certain information to the cabinet; require the cabinet to report certain information to the General Assembly upon request; establish penalties; amend KRS 304-17A.148 to cap the cost-sharing requirements for prescription insulin at $30 per 30 day supply; amend KRS 18A.225 to require the Kentucky Employee Health Plan to comply; EMERGENCY. |
| Index Headings of Original Version |
Diseases - Diabetes, prescription insulin drugs, cost sharing, cap Diseases - Diabetes, urgent-need insulin program and continuing access to insulin program, establishment Drugs and Medicines - Prescription insulin drugs, cost sharing, cap Drugs and Medicines - Urgent-need insulin program and continuing access to insulin program, establishment Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022 Effective Dates, Emergency - Urgent-need insulin program and continuing access to insulin program, establishment Insurance, Health - Prescription insulin drugs, cost sharing, cap Pharmacists - Urgent-need insulin program and continuing access to insulin program, establishment State Agencies - Cabinet for Health and Family Services, continuing access to insulin program Health Benefit Mandate - Urgent-need insulin program and continuing access to insulin program, establishment State Agencies - Cabinet for Health and Family Services, urgent-need insulin program Administrative Regulations and Proceedings - Cabinet for Health and Family Services, continuing access to insulin program Administrative Regulations and Proceedings - Cabinet for Health and Family Services, urgent-need insulin program Boards and Commissions - Cabinet for Health and Family Services, continuing access to insulin program, establishment Boards and Commissions - Cabinet for Health and Family Services, urgent-need insulin program, establishment Reports Mandated - Insulin manufacturers, urgent-need and continuing access to insulin programs, requirement |
| 01/13/21 |
|
|---|
Last updated: 11/9/2023 2:52 PM (EST)